Quick Facts

Share SHARE

UCB announced that the U.S. Food and Drug Administration has approved a supplemental new drug application (sNDA) for VIMPAT (lacosamide) C-V as monotherapy in the treatment of partial-onset seizures in patients with epilepsy aged 17 years and older. This is a new indication for VIMPAT which is already...

GE Healthcare, a unit of General Electric Co. (GE), announced that Vizamyl (flutemetamol (18F) solution for injection) has received marketing authorisation from the European Commission as a radiopharmaceutical medicinal product indicated for Positron Emission Tomography or PET imaging of beta amyloid...

Crown Holdings Inc. (CCK) said Monday that it agreed to acquire Empaque, a leading Mexican manufacturer of aluminum cans and ends, bottle caps and glass bottles for the beverage industry, from Dutch brewer Heineken N.V. (HINKY.PK), in a cash transaction valued at $1.225 billion, subject to adjustment. The...

ResMed (RMD) announced results from a study presented at the ESC Congress 2014 in Barcelona, Spain, looking at the use of the at-home, contactless, bedside SleepMinder device to diagnose sleep-disordered breathing or SDB, the most common co-morbidity in patients with heart failure or HF. The company...

Sanofi (SNY) and Regeneron Pharmaceuticals Inc. (REGN) announced detailed positive results from four Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia. Results from the four ongoing trials, all of which met their primary efficacy endpoint, will be presented today at a Hot Line...

Lockheed Martin (LMT), Saturday announced its partnership with Warsaw University has demonstrated the first phase of flight test and integration of unmanned aircraft platforms with an autonomous mission control system. Professor Janusz Narkiewicz, the leader and scientific manager of the project from...

Novartis (NVS), revealed its investigational heart failure medicine, LCZ696, which was considered to be superior to ACE-inhibitor enalapril on key endpoints in a heart failure study. LCZ696 is an Angiotensin Receptor Neprilysin Inhibitor and has a unique mode of action which is thought to reduce the...

Medical device company ArthroCare Corp.'s (ARTC, ARTC.PK) ex- chief executive officer Michael Baker and the company's former finance chief Michael Gluk were sentenced to imprisonment on Friday, after they were found guilty of plotting a $750 million securities fraud scheme. The court sentenced Baker...

Global alternative asset manager Carlyle Group L.P. (CG) has agreed to pay $115 million to settle a collusion case, which accused the company for conspiring with other private-equity firms to not to bid against one another in eight corporate takeovers that happened during the mid-2000s, according to...

Canadian coffee and dough-nut chain Tim Hortons, Inc.(THI, THI.TO) will have to pay C$345 million as termination fee to Burger King Worldwide, Inc. (BKW), if the former backs out from the $11 billion merger deal, stated a Burger King regulatory filing. Meanwhile, as per the filing, Burger King has...

Semiconductor company Microchip Technology Inc (MCHP), which held preliminary talks with CSR plc (CSRE, CSRXF.PK, CSR.L), including the possibility of a merger, said Friday that any offer for CSR is likely to be solely in cash, although Microchip reserves the right to vary the form of the consideration...

Fairfax Financial Holdings Ltd (FFH.TO, FFH_U.TO) Friday agreed to acquire all of the outstanding common shares of Canadian pet insurance provider Pethealth Inc (PTZ.TO) for $2.79 per share in cash. Also Fairfax will buy all of the outstanding preferred shares of Pethealth for a purchase price of...

Diversified utility company Vectren Corp (VVC) Friday closed the sale of its coal mining subsidiary, Vectren Fuels Inc, to Sunrise Coal LLC, an Indiana-based unit of Hallador Energy Coy (HNRG). The deal was announced in July. Prior to the sale, Vectren Fuels owned three underground coal mines in...

Briggs & Stratton Corp. (BGG) announced that it has acquired U.S. based Allmand Bros., Inc. for a total consideration of about $62 million in cash for all outstanding shares of Allmand, net of acquired cash. It is noted that Briggs & Stratton financed the transaction from cash on hand. Founded...

Pfenex Inc. (PFNX) posted second-quarter net loss attributable to common stockholders of $2.63 million or $1.67 per share, wider than $1.60 million or $1.04 per share in the comparable quarter last year. Revenue for the latest second quarter rose to $3.27 million from $2.31 million in the year-ago...